Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Choosing cryptocurrencies as a beginner can be daunting. This guide provides insights into the best investment options to start your journey.
23,437 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A State Street strategist says the Fed will cut rates three times in 2026, a view that clashes with current market pr...
Iranian strikes have sharply reduced Qatar's LNG output, cutting roughly 17% of capacity and threatening global suppl...
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
A missile strike on Qatar’s LNG facilities pushes oil and gas markets higher. Traders point to wall street buying the...
Software shares have slid toward what some call bargain territory, but a growing argument centers on whether hidden c...
Trinity Capital remains a high-yield fixture in venture lending, but a balance of losses, dilution, and rate shifts u...
When a single security gap triggers a major depeg, everyday investors feel the impact first. This article unpacks res...
Geopolitical tensions between the U.S. and Iran are dominating crypto moves, with Bitcoin and XRP trading in tight ra...
A real estate liquidity squeeze is unfolding as investors pull billions from property funds. Could this be the first ...
Tesla reports its first European sales uptick in over a year, a modest but meaningful turn that investors are watchin...
QVC is leaning into TikTok's live shopping fever as traditional TV fades. The move aims to spark a new growth engine ...